Evidence map›Paper›PMID 38987232›Full record

ArticleBJS open2024

Complications and adverse events in lymphadenectomy of the inguinal area: worldwide expert consensus.

René Sotelo, Aref S Sayegh, Luis G Medina, Laura C Perez, Anibal La Riva, Michael B Eppler, José Gaona, Marcos Tobias-Machado, Philippe E Spiess, Curtis A Pettaway and 37 more

Erratum issuedAbstract readConsensus Statement
In one paragraph

Article in BJS open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

47 authors.

René SoteloCatherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Aref S SayeghCatherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.ORCID 0000-0001-9320-2987
Luis G MedinaCatherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Laura C PerezCatherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Anibal La RivaCatherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Michael B EpplerCatherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
José GaonaUniversidad de Santander, Instituto Uromédica, Bucaramanga, Colombia.
Marcos Tobias-MachadoDepartment of Urology, Instituto do Câncer Arnaldo Vieira de Carvalho, São Paulo, Brazil.
Philippe E SpiessDepartment of Genitourinary Oncology and Tumor Biology, Moffitt Cancer Center, Tampa, Florida, USA.
Curtis A PettawayThe University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA.
Antonio Carlos Lima PompeoDepartment of Urology, Faculdade de Medicina do ABC, São Paulo, Brazil.
Pablo Aloisio Lima MattosDepartment of Urology, Associação Piauiense de Combate ao Câncer, Teresina, Piauí, Brazil.
Timothy G WilsonDepartment of Urology, Providence St. John's Cancer Institute, Santa Monica, California, USA.
Gustavo M VilloldoDepartment of Urology, Instituto Alexander Fleming, Buenos Aires, Argentina.
Eric ChungDepartment of Urology, Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0003-3373-3668
Aldo SamaniegoDepartment of Urology, Servicio de Urología del Hospital Central del Instituto de Previsión Social, Asunción, Paraguay.
Antonio Augusto OrnellasDepartamento de Urologia, Instituto Nacional do Câncer do Brasil (INCA), Rio de Janeiro, Brazil.
Vladimir PinheiroDepartment of Urology, AC Camargo Cancer Center, São Paulo, Brazil.
Eder S BrazãoDepartment of Urology, AC Camargo Cancer Center, São Paulo, Brazil.
David Subira-RiosDepartment of Urology, Gregorio Marañon Universitary Hospital, Madrid, Spain.
Leandro KoifmanServiço de Urologia, Hospital Municipal Souza Aguiar, Rio de Janeiro, Rio de Janeiro, Brazil.
Stênio de Cassio ZequiDepartment of Urology, AC Camargo Cancer Center-São Paulo, São Paulo, Brazil.
Humberto M Pontillo ZDepartment of Urology, Sant Jaume of Calella Hospital, Barcelona, Spain.
José de Ribamar Rodrigues CalixtoDepartment of Medicine II, Federal University of Maranhão, São Luís, Massachusetts, Brazil.
Rafael Campos SilvaDepartment of Urology, Hospital Universitário Presidente Dutra-HUPD/UFMA, São Luís, Maranhão, Brazil.
B Mark SmithersUniversity of Queensland, Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.ORCID 0000-0002-8333-8685
Simone GarzonDepartment of Surgery, Dentistry, Pediatrics, and Gynecology, University of Verona, Verona, Italy.
Oliver HaaseDepartment of Surgery, University Medicine Berlin-Charité, Berlin, Germany.
Antonio SommarivaVeneto Institute of Oncology Institute Oncology Veneto, Istituto Di Ricovero e Cura a Carattere Scientifico, Padova, Italy.
Robert FruscioDepartment of Medicine and Surgery, University of Milan Bicocca, Azienda Socio Sanitaria Territoriale Monza, Italy.
Francisco MartinsDepartment of Urology, Centro Hospitalar Universitário Lisboa Norte, Hospital de Santa Maria, Lisbon, Portugal.
Pedro S de OliveiraDepartment of Urology, Centro Hospitalar Universitário Lisboa Norte, Hospital de Santa Maria, Lisbon, Portugal.
Giovanni Battista Levi SandriDepartment of Surgery, ASL Frosinone, Frosinone, Italy.
Marco ClementiDepartment of Medicine, Health and Life, University of L'Aquila, L'Aquila, AQ, Italy.
Juan AstiguetaDepartment of Urology, Universidad Privada Antenor Orrego, Trujillo, Perú.
Islam H MetwallySurgical Oncology Department, Oncology Center Mansoura University (OCMU), Mansoura, Egypt.
Rasiah BharathanDepartment of Gynaecological Oncology, Medical University of Vienna, Vienna, Austria.
Tarun JindalDepartment of Uro-oncology, Narayana Super Speciality Hospital, Howrah, India.
Yasuhiro NakamuraDepartment of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
Hisham Abdel MageedSurgical Oncology Department, National Cancer Institute Cairo University, Cairo, Egypt.
Sakthiushadevi JeevarajanDepartment of Surgical Oncology, Regional Cancer Centre, Kanchipuram, Tamil Nadu, India.ORCID 0000-0003-0118-3825
Ramón Rodriguez LayClinic Urology Service, Complejo Hospitalario Metropolitano, Madrid, Panama.
Herney Andrés García-PerdomoDivision of Urology/Urooncology, Department of Surgery, School of Medicine, Universidad del Valle, Cali, Colombia.
Omaira Rodríguez GonzálezChief of Surgical Department, Clínicas Caracas Hospital, Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela.
Saum GhodoussipourSections of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Inderbir GillCatherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Giovanni E CacciamaniCatherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInguinal lymph node dissection plays an important role in the management of melanoma, penile and vulval cancer. Inguinal lymph node dissection is associated with various intraoperative and postoperative complications with significant heterogeneity in classification and reporting. This lack of standardization challenges efforts to study and report inguinal lymph node dissection outcomes. The aim of this study was to devise a system to standardize the classification and reporting of inguinal lymph node dissection perioperative complications by creating a worldwide collaborative, the complications and adverse events in lymphadenectomy of the inguinal area (CALI) group.

methodsA modified 3-round Delphi consensus approach surveyed a worldwide group of experts in inguinal lymph node dissection for melanoma, penile and vulval cancer. The group of experts included general surgeons, urologists and oncologists (gynaecological and surgical). The survey assessed expert agreement on inguinal lymph node dissection perioperative complications. Panel interrater agreement and consistency were assessed as the overall percentage agreement and Cronbach's α.

resultsForty-seven experienced consultants were enrolled: 26 (55.3%) urologists, 11 (23.4%) surgical oncologists, 6 (12.8%) general surgeons and 4 (8.5%) gynaecology oncologists. Based on their expertise, 31 (66%), 10 (21.3%) and 22 (46.8%) of the participants treat penile cancer, vulval cancer and melanoma using inguinal lymph node dissection respectively; 89.4% (42 of 47) agreed with the definitions and inclusion as part of the inguinal lymph node dissection intraoperative complication group, while 93.6% (44 of 47) agreed that postoperative complications should be subclassified into five macrocategories. Unanimous agreement (100%, 37 of 37) was achieved with the final standardized classification system for reporting inguinal lymph node dissection complications in melanoma, vulval cancer and penile cancer.

conclusionThe complications and adverse events in lymphadenectomy of the inguinal area classification system has been developed as a tool to standardize the assessment and reporting of complications during inguinal lymph node dissection for the treatment of melanoma, vulval and penile cancer.

Indexed as

Delphi TechniqueInguinal CanalLymph Node ExcisionMelanomaPenile NeoplasmsPostoperative ComplicationsVulvar NeoplasmsFemaleHumansMaleSurveys and Questionnaires

Identifiers

PMID38987232
PMCPMC11236483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.